Primary small cell carcinoma of the esophagus: Review of 64 cases from a single institution

Diseases of the Esophagus

Volumn 27, Issue 2, 2014, Pages 152-158

  Zhu, Y ^a,b   Qiu, B ^a,b   Liu, H ^a,b   Li, Q ^a,b   Xiao, W ^a,b   Hu, Y ^a,b   Liu, M ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b Guangdong Esophageal Cancer Research Institute   (China)

Author keywords

Chemotherapy; Multimodality treatment; Prognosis; Small cell carcinoma of esophagus

Indexed keywords

CAPECITABINE; CARBOPLATIN; CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; IFOSFAMIDE; NIMOTUZUMAB; PACLITAXEL; PLATINUM; VINCRISTINE; VINDESINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; ECOG PERFORMANCE SCORE; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HAZARD RATIO; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LIVER METASTASIS; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MEDIAN SURVIVAL TIME; MEDICAL RECORD REVIEW; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RISK FACTOR; SCORING SYSTEM; SMALL CELL CARCINOMA; SMALL CELL CARCINOMA OF ESOPHAGUS; SURVIVAL TIME; SYSTEMIC THERAPY; TREATMENT OUTCOME; TREND STUDY; TUMOR VOLUME; UNIVERSITY HOSPITAL;

CHEMOTHERAPY; MULTIMODALITY TREATMENT; PROGNOSIS; SMALL CELL CARCINOMA OF ESOPHAGUS;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84893013199     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/dote.12069     Document Type: Article

References (23)

1. Pisani P, Parkin D M, Bray F etal. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999; 83: 18-29.
2. McKeown F. Oat-cell carcinoma of the oesophagus. J Pathol Bacteriol 1952; 64: 889-891.
3. Koide N, Saito H, Suzuki A etal. Clinicopathologic features and histochemical analyses of proliferative activity and angiogenesis in small cell carcinoma of the esophagus. J Gastroenterol 2007; 42: 932-938.
4. Fujita H, Kakegawa T, Yamana H etal. Mortality and morbidity rates, post operative course, quality of life and prognosis after radical lymphadenectomy for esophageal cancer. Ann Surg 1995; 222: 654-662.
5. Brenner B, Tang L H, Klimstra D S etal. Small-cell carcinomas of the gastrointestinal tract: a review. J Clin Oncol 2004; 22: 2730-2739.
6. Casas F, Ferrer F, Farrus B etal. Primary small cell carcinoma of the esophagus. Cancer 1997; 80: 1366-1372.
7. Lee S S, Ha H K, Kim A Y etal. Primary extrapulmonary small cell carcinoma involving the stomach or duodenum or both: findings on CT and barium studies. AJR Am J Roentgenol 2003; 180: 1325-1329.
8. Vos B, Rozema T, Miller R C etal. Small cell carcinoma of the esophagus: a multicentre Rare Cancer Network study. Dis Esophagus 2011; 24: 258-264.
9. Tennvall J, Johansson L, Albertsson M. Small cell carcinoma of the oesophagus: a clinical and immunohistopathological review. Eur J Surg Oncol 1990; 16: 109-115.
10. Lv J, Liang J, Wang J etal. Primary small cell carcinoma of the esophagus. J Thorac Oncol 2008; 3: 1460-1465.
11. Ugras S, Akpolat N, Er M etal. Primary composite tumor with bipartite differentiation of the esophagus. Acta Chir Belg 2000; 100: 39-43.
12. Mandard A M, Chasle J, Marnay J etal. Autopsy findings in 111 cases of esophageal cancer. Cancer 1981; 48: 329-335.
13. Attar B M, Levendoglu H, Rhee H. Small cell carcinoma of the esophagus. Report of three cases and review of the literature. Dig Dis Sci 1990; 35: 145-152.
14. Ku G Y, Minsky B D, Rusch V W etal. Small-cell carcinoma of the esophagus and gastroesophageal junction: review of the Memorial Sloan-Kettering experience. Ann Oncol 2008; 19: 533-537.
15. Hudson E, Powell J, Mukherjee S etal. Small cell oesophageal carcinoma: an institutional experience and review of the literature. Br J Cancer 2007; 96: 708-711.
16. Noda K, Nishiwaki Y, Kawahara M etal. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med 2002; 346: 85-91.
17. NAkajima Y, Zenda S, Minashi K etal. Non-surgical approach to small cell carcinoma of the esophagus: does this rare disease have the same tumor behavior as SCLC? Int J Clin Oncol 2011; 17: 610-615.
18. Nishimaki T, Suzuki T, Nakagawa S etal. Tumor spread and outcome of treatment in primary esophageal small cell carcinoma. J Surg Oncol 1997; 64: 130-134.
19. Brock M V, Hooker C M, Syphard J E etal. Surgical resection of limited diseases small cell lung cancer in the new era of platinum chemotherapy: its time has come. J Thorac Cardiovasc Surg 2005; 129: 64-72.
20. Tanaka T, Matono S, Nagano T etal. Surgical management for small cell carcinoma of the esophagus. Dis Esophagus 2010; 23: 502-505.
21. Brenner B, Tang L H, Klimstra D S, Kelsen D P. Small-cell carcinomas of the gastrointestinal tract: a review. J Clin Oncol 2004; 22: 2730 -2739.
22. Chen S B, Yang J S, Yang W P etal. Treatment and prognosis of limited disease primary small cell carcinoma of esophagus. Dis Esophagus 2011; 24: 114-119.
23. Auperin A, Arriagada R, Pignon J P etal. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 1999; 341: 476-484.